Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected latin American children

Pediatric Infectious Disease Journal

Volumn 32, Issue 7, 2013, Pages 757-759

  Hazra, Rohan ^a   Hance, Laura Freimanis ^b   Monteiro, Jacqueline Pontes ^c   Ruz, Noris Pavia ^d   Machado, Daisy Maria ^e   Saavedra, Mariza ^f   Motta, Fabrizio ^g   Harris, D Robert ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WESTAT   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f Hospital Federal dos Servidores do Estado   (Brazil)

^g Irmandade da Santa Casa de Misericordia de Porto Alegre   (Brazil)

Author keywords

Antiretroviral therapy; HIV; Insulin resistance; Pediatric

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PERINATAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD;

BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INSULIN RESISTANCE; LATIN AMERICA; LIPIDS; MALE; PROSPECTIVE STUDIES;

EID: 84883258913     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318286c774     Document Type: Article

References (10)

1. Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med. 2010;61:169-185.
2. Beregszaszi M, Dollfus C, Levine M, et al. Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children. J Acquir Immune Defic Syndr. 2005;40:161-168.
3. Amaya RA, Kozinetz CA, McMeans A, et al. Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2002;21:405-410.
4. Rosso R, Parodi A, d'Annunzio G, et al. Evaluation of insulin resistance in a cohort of HIV-infected youth. Eur J Endocrinol. 2007;157:655-659.
5. Lee B, Aurpibul L, Sirisanthana V, et al. Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand. HIV Med. 2009;10:72-78.
6. Dimock D, Thomas V, Cushing A, et al. Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood. Metab Clin Exp. 2011;60:874-880.
7. Geffner ME, Patel K, Miller TL, et al.; Pediatric HIV/AIDS Cohort Study. Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study. Horm Res Paediatr. 2011;76:386-391.
8. Hazra R, Stoszek SK, Freimanis Hance L, et al.; NISDI Pediatric Study Group 2008. Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. Int J Epidemiol. 2009;38:1207-1214.
9. Aldrovandi GM, Lindsey JC, Jacobson DL, et al.; Pediatric AIDS Clinical Trials Group P1045 team. Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. AIDS. 2009;23:661-672.
10. Chantry CJ, Hughes MD, Alvero C, et al.; PACTG 1010 Team. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy. Pediatrics. 2008;122:e129-e138. Development Development